Filing Details

Accession Number:
0001209191-23-013398
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-02-27 19:14:01
Reporting Period:
2023-02-23
Accepted Time:
2023-02-27 19:14:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1802768 Royalty Pharma Plc RPRX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1814899 W. George Lloyd C/O Royalty Pharma Plc
110 East 59Th Street
New York NY 10022
Evp, Investments & Clo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Ordinary Shares Disposition 2023-02-23 25,000 $37.27 325,000 No 4 S Indirect By GWL 2014 G, LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By GWL 2014 G, LLC
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Class A Ordinary Shares 495,860 Indirect By GWL 2013 NG, LLC
Class A Ordinary Shares 273,960 Indirect By IRA
Class A Ordinary Shares 130,000 Indirect By GWL 2020 G, LLC
Class A Ordinary Shares 3,000 Direct
Class A Ordinary Shares 4,011 Indirect By Spouse
Footnotes
  1. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.19 to $37.37 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.